Actual enrollment decreased by 1 participants
Before: 102 participants (actual). After: 101 participants (actual).
Study sponsor: PTC Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 102 participants (actual). After: 101 participants (actual).
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Number of Participants With Adverse Events (AEs). After: Measure: Number of Participants With Treatment-emergent Adverse Events (TEAEs).